Europe Amgen Scholars Alumni Travel Award Cycle Opens
Mar 30, 2016 10:15 AM ET
Campaign:
Amgen Scholars Program
Application guidelines are as follows:
Eligibility
- All alumni of the European Amgen Scholars Programme currently enrolled in an PhD or MD-PhD programme are welcome to apply
- Funding will support attendance at scientific meetings, conferences and workshops; poster or oral presentation is not a pre-requisite for funding
- On acceptance of an award under the scheme, successful applicants agree to write a short report for the Amgen Scholars Community website within 2 months of the event attended
- Successful applicants will not be eligible to apply in subsequent years; unsuccessful applicants may reapply
Submission of applications
- Applications should be made on the official form, and submitted electronically to the Amgen Scholars European Coordinating Centre using the e-mail address: amgenecc@admin.cam.ac.uk
- Please title your e-mail 'Application to the ASP alumni scheme'.
- You will also require an academic referee to submit a letter of support, either electronically or by post
- Applications and letters of support should be submitted by Wednesday 20th April 2016
- Applicants will be notified of the outcome of their application by Thursday 12th May 2016
Support available
- The scheme provides support for costs associated with travel, registration and accommodation, up to a maximum of £500 for a European conference or £1000 for an international conference
- A limited amount of funding is available. Annually we expect to make up to 6-8 awards to alumni of the European Amgen Scholars Programme
Assessment process
- Applications will be judged on academic achievement to date, and relevance of the meeting, conference or workshop to your continued scientific development.
----------------
To learn more about the Amgen Scholars Program, please visit our website and check out the #AmgenScholars hashtag on Twitter. Visit AmgenInspires.com and follow @AmgenFoundation to stay up to date with all STEM-related news from the Amgen Foundation.